Limited lists of drugs: lessons from abroad.
作者信息
Sanders J C
出版信息
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):710. doi: 10.1136/bmj.290.6469.710.
Abstract
摘要
相似文献
1
Limited lists of drugs: lessons from abroad.
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):710. doi: 10.1136/bmj.290.6469.710.
2
Limited lists of drugs: lessons from abroad.
Br Med J (Clin Res Ed). 1985 Feb 16;290(6467):532-4. doi: 10.1136/bmj.290.6467.532.
3
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations.
Clin Ther. 2010 Aug;32(9):1651-61. doi: 10.1016/j.clinthera.2010.08.006.
4
Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.
Pharmacoeconomics. 1994;6 Suppl 1:15-21. doi: 10.2165/00019053-199400061-00007.
5
European courts. CJEC 2003/3 case C-156/01, Van der Duin.
Eur J Health Law. 2003 Sep;10(3):317-8.
6
Reimbursement for mental health services in primary care: lessons from the Canadian experience.
J Fam Pract. 1981 Nov;13(6):795-6.
7
Law. Traveller's checks.
Health Serv J. 2002 May 23;112(5806):39, 41.
8
Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan.
Kidney Int. 2011 Feb;79(3):265-7. doi: 10.1038/ki.2010.459.
9
Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
Fed Regist. 1992 Nov 2;57(212):49397-412.
10
[Off-label use and the 'explanation'].
Tijdschr Diergeneeskd. 2003 May 15;128(10):340-1.
Zotero 插件